fbpx
News
June 23, 2017

Congress Holds Hearing to Examine Ethical Responsibilities Regarding Attorney Advertising

Today, the House of Representatives Subcommittee on the Constitution and Civil Justice held a hearing, “Examining Ethical Responsibilities Regarding Attorney Advertising,” to discuss the dangers associated with trial lawyer drug advertising.

We applaud the Subcommittee for taking action on this issue as trial lawyer drug ads have the potential to impact public health.

“Alarmist plaintiff lawyer ads targeting prescription drugs can literally scare people to death,” said Lisa A. Rickard, president of ILR. “Congress is right to examine their impact on the public’s health and to consider how this can be remedied.”

Ahead of the hearing, ILR released a national survey on the public health consequences of trial lawyer drug advertising. One in four respondents taking targeted prescriptions said they would immediately stop taking their medication- without consulting their doctor- after seeing a trial lawyer ad. Additionally, 84% of Americans say they would be concerned if they saw a lawsuit ad about medicine they were taking.

Witnesses at the hearing included: Dr. Ilana Kutinsky MD, Director of Atrial Fibrillation Services; Dr. Shawn Fleming MD, a Vascular Surgeon; Lynda Shely from The Shely Firm; and Elizabeth Tippett, Assistant Professor at the University of Oregon School of Law. You can view all of the hearing testimony here

Click here to read more in an op-ed in The Hill newspaper by Lisa Rickard. 

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Review Settings